BioMarin Pharmaceutical, Inc. (BMRN)
51.81
-1.43
(-2.69%)
USD |
NASDAQ |
May 15, 16:00
51.74
-0.07
(-0.14%)
After-Hours: 20:00
BioMarin Pharmaceutical Shareholders Equity (Quarterly) : 6.212B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 491.41M |
| Mirum Pharmaceuticals, Inc. | 242.49M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Regeneron Pharmaceuticals, Inc. | 31.42B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.591B |
| Total Liabilities (Quarterly) | 2.379B |
| Debt to Equity Ratio | 0.2328 |
| Current Ratio | 5.806 |
| Net Debt Paydown Yield | -1.46% |